Vaxart Secures New European Patent Covering Oral Norovirus Vaccine Technology

05:37 PM EDT, 08/26/2026 (MT Newswires) -- Vaxart (VXRT) won a new patent from the European Patent Office that extends intellectual property protection for its norovirus vaccine program through at least 2036 across key European markets. The patent further protects core intellectual property for the company's oral recombinant norovirus vaccine candidate, Vaxart said Wednesday in a statement.